Among the most popular fund investment industries, there are Biotechnology, Artificial Intelligence. The fund has no exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline XtalPi, Biocytogen Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019.
We also calculated 1 valuable employee in our database.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the China Life Healthcare Fund, startups are often financed by ZhenFund, Tencent Holdings, Sequoia Capital China. The meaningful sponsors for the fund in investment in the same round are Yael Capital Management Limited, SIG China (SIG Asia Investments), SDIC Venture Capital.
Related Funds
Fund Name | Location |
Beyond Ventures | China, Hong Kong, New Territories |
Canadian Pacific Railway | Canada, Manitoba, Winnipeg |
Centre Street Partners | New York, New York, United States |
Epiris | England, London, United Kingdom |
Fyrfly Venture Partners | California, Menlo Park, United States |
GeNi VC | Distrito Federal, Mexico, Mexico City |
Gerbig Ventures | - |
Highland Consumer Partners | Massachusetts, United States, Wellesley |
IFX Corporation | Florida, Hollywood, United States |
Ininvest | - |
Joseph Investment | Beijing, Beijing, China |
Junrun Capital | China, Ningbo, Zhejiang |
Kestrel Capital | Kenya, Nairobi, Nairobi Area |
QED Innovation Labs | India, Maharashtra, Mumbai |
Real Capital Analytics | New York, New York, United States |
RIC Capital Management | China, Shanghai |
Spring Creek Group | Seattle, United States, Washington |
Summa Digital | Stockholm, Stockholm County, Sweden |
Tarrant Venture Partners | Fort Worth, Texas, United States |
Umoe | Akershus, Lysaker, Norway |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Valgen Medtech | $100M | 06 May 2021 | Shangcheng District, Zhejiang, China | ||
Sepax Technologies | $30M | 18 Mar 2021 | Delaware, Ohio, United States | ||
XtalPi | $46M | 25 Oct 2018 | United States, Cambridge |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Valgen Medtech | $100M | 06 May 2021 | Shangcheng District, Zhejiang, China | ||
Sepax Technologies | $30M | 18 Mar 2021 | Delaware, Ohio, United States | ||
XtalPi | $46M | 25 Oct 2018 | United States, Cambridge |